Literature DB >> 19204960

Total synthesis of rapamycin.

Steven V Ley1, Miles N Tackett, Matthew L Maddess, James C Anderson, Paul E Brennan, Michael W Cappi, Jag P Heer, Céline Helgen, Masakuni Kori, Cyrille Kouklovsky, Stephen P Marsden, Joanne Norman, David P Osborn, María A Palomero, John B J Pavey, Catherine Pinel, Lesley A Robinson, Jürgen Schnaubelt, James S Scott, Christopher D Spilling, Hidenori Watanabe, Kieron E Wesson, Michael C Willis.   

Abstract

For over 30 years, rapamycin has generated a sustained and intense interest from the scientific community as a result of its exceptional pharmacological properties and challenging structural features. In addition to its well known therapeutic value as a potent immunosuppressive agent, rapamycin and its derivatives have recently gained prominence for the treatment of a wide variety of other human malignancies. Herein we disclose full details of our extensive investigation into the synthesis of rapamycin that culminated in a new and convergent preparation featuring a macro-etherification/catechol-templating strategy for construction of the macrocyclic core of this natural product.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204960     DOI: 10.1002/chem.200801656

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

2.  Rapalogues as hCES2A Inhibitors: In Vitro and In Silico Investigations.

Authors:  Cheng-Cheng Shi; Yun-Qing Song; Rong-Jing He; Xiao-Qing Guan; Li-Lin Song; Shi-Tong Chen; Meng-Ru Sun; Guang-Bo Ge; Li-Rong Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

Review 3.  Synthesis and biological evaluation of rapamycin-derived, next generation small molecules.

Authors:  Shiva Krishna Reddy Guduru; Prabhat Arya
Journal:  Medchemcomm       Date:  2017-11-22       Impact factor: 3.597

4.  Site-specific bioalkylation of rapamycin by the RapM 16-O-methyltransferase.

Authors:  Brian J C Law; Anna-Winona Struck; Matthew R Bennett; Barrie Wilkinson; Jason Micklefield
Journal:  Chem Sci       Date:  2015-03-02       Impact factor: 9.825

5.  A selective removal of the secondary hydroxy group from ortho-dithioacetal-substituted diarylmethanols.

Authors:  Anna Czarnecka; Emilia Kowalska; Agnieszka Bodzioch; Joanna Skalik; Marek Koprowski; Krzysztof Owsianik; Piotr Bałczewski
Journal:  Beilstein J Org Chem       Date:  2018-05-29       Impact factor: 2.883

6.  Callipeltosides A, B and C: Total Syntheses and Structural Confirmation.

Authors:  James R Frost; Colin M Pearson; Thomas N Snaddon; Richard A Booth; Richard M Turner; Johan Gold; David M Shaw; Matthew J Gaunt; Steven V Ley
Journal:  Chemistry       Date:  2015-07-31       Impact factor: 5.236

7.  An Effective Bifunctional Aldehyde Linchpin for Type II Anion Relay Chemistry: Development and Application to the Synthesis of a C16-C29 Fragment of Rhizopodin.

Authors:  Bruno Melillo; Ming Z Chen; Roberto Forestieri; Amos B Smith
Journal:  Org Lett       Date:  2015-12-07       Impact factor: 6.005

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.